<DOC>
	<DOC>NCT01525212</DOC>
	<brief_summary>The purpose of this study is to determine the change from baseline in HCV Ribonucleic acid (RNA) on Day 4 following three days of dosing with BMS-929075 in chronically genotype subtype 1a and 1b HCV infected subjects</brief_summary>
	<brief_title>Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<criteria>Men and women, ages 18 to 65 years, inclusive Subjects who are naive to HCV treatment, defined as no previous exposure to an Interferon (IFN), Ribavirin (RBV); or any HCVspecific direct acting antiviral or experimental therapy HCV genotype 1a or 1b only HCV RNA viral load of ≥ 100,000 IU/mL Have one of the following: i) Documented Fibrotest score of ≤ 0.72 and AST to platelet ratio index (APRI) ≤ 2; or ii) Documented liver biopsy within 12 months preceding Day 1 showing absence of cirrhosis Body Mass Index (BMI) of 18.0 to 35.0 kg/m2, inclusive Any significant acute or chronic medical illness History of adrenal gland disease, including but not limited to adrenal insufficiency or Cushing's syndrome Current or recent (within 3 months of study drug administration) gastrointestinal disease Any major surgery within 4 weeks of study drug administration Any gastrointestinal surgery that could impact upon the absorption of study drug Positive for hepatitis B surface antigen (HBsAg) Positive for Human Immunodeficiency Virus (HIV) 1 and/or 2 antibodies Smoking &gt; 10 cigarettes per day Alanine aminotransferase (ALT) or Aspartate aminotransferase (AST) &gt; 5x upper limit of normal (ULN) Total Bilirubin ≥ 1.5x ULN Hemoglobin &lt; 10 g/dL Platelets &lt; 75,000 cell/μL ALC (absolute lymphocyte count) &lt; 1000 cell/μL Creatinine clearance (as estimated by method of Cockcroft and Gault) less than 60 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>